Completed
Topics
Psychiatric illnesses - including major depressive disorder, anxiety disorder, posttraumatic stress disorder, and substance use disorders - are widely prevalent and represent a significant health care burden worldwide. For many affected people, existing treatments provide incomplete relief from disruptive and disabling symptoms. On March 29-30, 2022, this workshop will explore the therapeutic use of psychedelics and entactogens for these disorders. Speakers will discuss the current state of knowledge regarding mechanisms of action and clinical efficacy; considerations for research, clinical trial design, and regulatory approval; bioethical and legal issues; and opportunities to move the field forward.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.
Discover
Events
Convening Activities
Engage
Work with us